MUMBAI, India, Aug. 10 -- Intellectual Property India has published a patent application (202647091688 A) filed by Sunrock Biopharma S. L.; and Tohoku University on July 28, 2026, for Anti-Ccr9 Antibody.
Inventors include Simn Buela, Laureano; Garrido Cuesta, Pablo; Prez Daz, Amparo; Lvarez Coiradas, Elia; Kato, Yukinari; Kato, Mika; Kontermann, Roland; Seifert, Oliver; and Nowack, Helena.
The application for the patent was published on July 31, 2026, under issue no. 31/2026.
Abstract: The present invention provides an anti-CCR9 antibody or antigen binding fragment thereof comprising a variable light chain comprising SEQ ID NO:1 or a variant thereof having at least 95% sequence identity to SEQ ID NO:1, wherein the variable light chain comprises a CDR-L1 comprising the amino acid sequence RSSQSLXHSNGXTFLH (SEQ ID NO: 2), a CDR-L2 comprising the amino acid sequence KVSNRFS (SEQ ID NO: 3) and a CDR-L3 comprising the amino acid sequence SQTTHXPWT (SEQ ID NO: 4), wherein X can be any amino acid. Also provided is the anti-CCR9 antibody or antigen binding fragment thereof for use in the treatment or prevention of a disease, as well as methods of diagnosis and antibody drug conjugates.
Disclaimer: Curated by HT Syndication.
